The primary findings are as follows: (1) A biomarker panel comprising common core genes, specifically CXCL10, CXCL9, AQP9, SPP1, and MT1M, effectively distinguished CD/RA samples from normal samples in both discovery and validation cohorts. The gene discussed is CXCL10; the disease is rheumatoid arthritis.